AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2021

Feb 12, 2021

34023_dirs_2021-02-12_ca04498f-5b00-4819-a11d-a00adea591ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2021-02-10

Reporting Person: O'Day Steven J (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to buy)	$3.23	2031-01-04	Common Stock (300000)		Direct
Restricted Stock Units	$		Common Stock (100000)		Direct

Footnotes

F1: Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (the "2019 Plan") and vests over three years with one-third of the award vesing on each of January 4,
2022, 2023 and 2024 (provided Mr. O'Day maintains a service relationship with the Company though each such vesting date).

F2: Restricted Stock Units awarded in accordance with the 2019 Plan and fully vest on January 4, 2022 (provided Mr. O'Day maintains a service relationship with the Company through such
vesting date).